<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatrician (St. Petersburg)</journal-id><journal-title-group><journal-title xml:lang="en">Pediatrician (St. Petersburg)</journal-title><trans-title-group xml:lang="ru"><trans-title>Педиатр</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-7850</issn><issn publication-format="electronic">2587-6252</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">529684</article-id><article-id pub-id-type="doi">10.17816/PED14237-47</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Presence of uveitis as indicator of juvenile idiopathic arthritis severity: results of a retrospective cohort study</article-title><trans-title-group xml:lang="ru"><trans-title>Наличие увеита как показатель тяжести течения ювенильного идиопатического артрита: результаты ретроспективного когортного исследования</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="spin">8475-5794</contrib-id><name-alternatives><name xml:lang="en"><surname>Yakovlev</surname><given-names>Alexandr A.</given-names></name><name xml:lang="ru"><surname>Яковлев</surname><given-names>Александр Александрович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Resident Doctor, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>ординатор, кафедра госпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">1625-9960</contrib-id><name-alternatives><name xml:lang="en"><surname>Gaidar</surname><given-names>Ekaterina V.</given-names></name><name xml:lang="ru"><surname>Гайдар</surname><given-names>Екатерина Владимировна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Rheumatologist, Pediatric Department No. 3</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-ревматолог, педиатрическое отделение № 3</p></bio><email>gaidare85@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">4260-5379</contrib-id><name-alternatives><name xml:lang="en"><surname>Belozerov</surname><given-names>Konstantin E.</given-names></name><name xml:lang="ru"><surname>Белозеров</surname><given-names>Константин Евгеньевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgraduate Student, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>аспирант кафедры госпитальной педиатрии</p></bio><email>biancolago@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">5822-8930</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaneva</surname><given-names>Maria A.</given-names></name><name xml:lang="ru"><surname>Канева</surname><given-names>Мария Александровна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Rheumatologist, Pediatric Department No. 3</p></bio><bio xml:lang="ru"><p>врач-ревматолог, педиатрическое отделение № 3</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kononov</surname><given-names>Anatolii V.</given-names></name><name xml:lang="ru"><surname>Кононов</surname><given-names>Анатолий Викторович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ophthalmologist, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>врач-офтальмолог, кафедра госпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">4088-4272</contrib-id><name-alternatives><name xml:lang="en"><surname>Sorokina</surname><given-names>Lyubov S.</given-names></name><name xml:lang="ru"><surname>Сорокина</surname><given-names>Любовь Сергеевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Rheumatologist, Pediatric Department No. 3</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-ревматолог, педиатрическое отделение № 3</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">3709-3195</contrib-id><name-alternatives><name xml:lang="en"><surname>Isupova</surname><given-names>Evgeniya A.</given-names></name><name xml:lang="ru"><surname>Исупова</surname><given-names>Евгения Алексеевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Rheumatologist, Pediatric Department No. 3</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-ревматолог, педиатрическое отделение № 3</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">3528-1558</contrib-id><name-alternatives><name xml:lang="en"><surname>Chikova</surname><given-names>Irina A.</given-names></name><name xml:lang="ru"><surname>Чикова</surname><given-names>Ирина Александровна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate Professor, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент, кафедра госпитальной педиатрии, заведующая учебной частью</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">2241-3508</contrib-id><name-alternatives><name xml:lang="en"><surname>Masalova</surname><given-names>Vera V.</given-names></name><name xml:lang="ru"><surname>Масалова</surname><given-names>Вера Васильевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant Professor, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>ассистент, кафедра госпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">4152-4976</contrib-id><name-alternatives><name xml:lang="en"><surname>Dubko</surname><given-names>Margarita F.</given-names></name><name xml:lang="ru"><surname>Дубко</surname><given-names>Маргарита Федоровна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate Professor, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент, кафедра госпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">8496-2970</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikitina</surname><given-names>Tatiana N.</given-names></name><name xml:lang="ru"><surname>Никитина</surname><given-names>Татьяна Николаевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Assistant Professor, Ophthalmology Department</p></bio><bio xml:lang="ru"><p>канд. мед. наук, ассистент, кафедра офтальмологии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">9114-0435</contrib-id><name-alternatives><name xml:lang="en"><surname>Kalashnikova</surname><given-names>Olga V.</given-names></name><name xml:lang="ru"><surname>Калашникова</surname><given-names>Ольга Валерьевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate Professor, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент, кафедра госпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">8175-0010</contrib-id><name-alternatives><name xml:lang="en"><surname>Chasnyk</surname><given-names>Vyacheslav G.</given-names></name><name xml:lang="ru"><surname>Часнык</surname><given-names>Вячеслав Григорьевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Dr. Sci. (Med.), Professor, Head of the Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>д-р. мед. наук, профессор, заведующий кафедрой гоcпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">7257-0795</contrib-id><name-alternatives><name xml:lang="en"><surname>Kostik</surname><given-names>Mikhail M.</given-names></name><name xml:lang="ru"><surname>Костик</surname><given-names>Михаил Михайлович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Dr. Sci. (Med.), Professor, Department of Hospital Pediatrics</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, кафедра госпитальной педиатрии</p></bio><email>alexandr.med18@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Saint Petersburg State Pediatric Medical University</institution></aff><aff><institution xml:lang="ru">Санкт-Петербургский государственный педиатрический медицинский университет</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-07-06" publication-format="electronic"><day>06</day><month>07</month><year>2023</year></pub-date><volume>14</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>37</fpage><lpage>47</lpage><history><date date-type="received" iso-8601-date="2023-07-04"><day>04</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-07-04"><day>04</day><month>07</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2023,</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/pediatr/article/view/529684">https://journals.eco-vector.com/pediatr/article/view/529684</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Juvenile idiopathic arthritis is the most common rheumatic disease in children. A frequent extra-articular manifestation of juvenile idiopathic arthritis is uveitis, which is a serious clinical diagnostic problem in routine pediatric practice. Among the known risk factors for uveitis are the early age of the juvenile idiopathic arthritis onset, oligoarticular subtype, seropositivity by antinuclear factor.</p> <p><bold>AIM:</bold> to evaluate the influence of presence of uveitis on the course of juvenile idiopathic arthritis.</p> <p><bold>MATERIALS AND METHODS: </bold>A single-center retrospective study included 520 patients with uveitis. The analysis was carried out among patients who developed (<italic>n</italic> = 116) and did not develop (<italic>n</italic> = 404) uveitis. The minimum follow-up period was 2 years, for patients who did not develop uveitis.</p> <p><bold>RESULTS: </bold>Uveitis was diagnosed in 116 (22.3%) children with juvenile idiopathic arthritis. Most often, uveitis occurred in patients with oligoarthritis and psoriatic arthritis. When comparing the features of the articular status of patients with juvenile idiopathic arthritis who developed and did not develop uveitis, a lower frequency of involvement of the cervical spine, temporomandibular, shoulder, elbow, wrist, proximal and distal interphalangeal joints, hip, talus-heel joint, as well as a smaller number of active joints in children with uveitis was found. Patients with uveitis received methotrexate therapy more often, cumulative doses of corticosteroids were lower, the frequency of prescribing genetically engineered biological drugs was approximately the same in both groups. Remission of arthritis was achieved more often, but the proportion of children who developed an exacerbation was higher. When calculating the risk factors of uveitis by binary logistic regression, it was found that the main predictors of uveitis were oligoarthritis, the number of active joints &lt;8, seropositivity by antinuclear factor and recurrent course of arthritis. The difference in the frequency of achieving remission may be due to more aggressive systemic therapy in the presence of uveitis.</p> <p><bold>CONCLUSIONS: </bold>Children with uveitis have a more severe course of juvenile idiopathic arthritis and may require more aggressive immuno-suppressive therapy. Further studies are required to determine the prognostic role of uveitis in the course and outcomes of juvenile idiopathic arthritis.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность. </bold>Ювенильный идиопатический артрит — наиболее распространенное ревматическое заболевание у детей. Частым внесуставным его сиптомом является увеит — серьезная клиническая проблема диагностики в рутинной педиатрической практике. Среди известных факторов риска увеита выделяют дебют в раннем возрасте ювенильного идиопатического артрита, олигоартикулярный подтип, серопозитивность по антинуклеарному фактору.</p> <p><bold>Цель </bold>— оценить влияние наличия увеита на течение ювенильного идиопатического артрита.</p> <p><bold>Материалы и методы. </bold>Одноцентровое ретроспективное исследование включает 520 пациентов, страдающих ювенильным идиопатическим артритом с увеитом. Анализ проводился среди пациентов, у которых развился (<italic>n</italic> = 116) и не развился (<italic>n</italic> = 404) увеит. Минимальный срок наблюдения составил 2 года для пациентов, у которых не развился увеит.</p> <p><bold>Результаты.</bold> Увеит был диагностирован у 116 (22,3 %) детей с ювенильным идиопатическим артритом. Чаще всего увеит встречался у пациентов с олигоартритом и псориатическим артритом. При сопоставлении особенностей суставного статуса пациентов с ювенильным идиопатическим артритом, с увеитом и без него, установлена меньшая частота вовлечения шейного отдела позвоночника, височно-нижнечелюстного, плечевого, локтевого, лучезапястных, проксимальных и дистальных межфаланговых суставов, тазобедренного, таранно-пяточного сустава, а также меньшее число активных суставов у детей с увеитом. Пациенты с увеитом чаще получали терапию метотрексатом, кумулятивные дозы кортикостероидов были меньше, частота назначения генно-инженерных биологических препаратов примерно одинаковая в обеих группах. Ремиссия по артриту достигалась чаще, однако доля детей, у которых развилось обострение, была выше. При расчете факторов риска увеита методом бинарной логистической регрессии, установлено, что основными предикторами увеита были олигоартрит, число активных суставов менее 8, серопозитивность по антинуклеарному фактору и рецидивирующее течение артрита. Разница в частоте достижения ремиссии может быть обусловлена более агрессивной системной терапией при наличии увеита.</p> <p><bold>Выводы.</bold> Дети с увеитом имеют более тяжелое течение ювенильного идиопатического артрита и могут требовать более агрессивной иммуносупрессивной терапии. Требуются дальнейшие исследования для оценки прогностической роли наличия увеита в течении и исходах ювенильного идиопатического артрита.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>uveitis</kwd><kwd>juvevile idiopathiv arthritis</kwd><kwd>iridocyclitis</kwd><kwd>methotrexate</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>увеит</kwd><kwd>ювенильный идиопатический артрит</kwd><kwd>иридоциклит</kwd><kwd>метотрексат</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Avanesyan RI, Avdeeva TG, Alekseeva EI, et al. Pediatriya. Moscow: GEOTAR-Media, 2009. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Аванесян Р.И., Авдеева Т.Г., Алексеева Е.И., и др. Педиатрия. Москва: ГЭОТАР-Медиа, 2009.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Gaidar EV, Kostik MM, Snegireva LS, et al. Outcomes of treatment of juvenile idiopathic arthritis related uveitis with TNF-alpha inhibitors. Pediatrician (St. Petersburg). 2014;5(4):60–64. (In Russ.) DOI: 10.17816/PED5460-64</mixed-citation><mixed-citation xml:lang="ru">Гайдар Е.В., Костик М.М., Снегирева Л.С., и др. Результаты лечения увеита, ассоциированного с ювенильным идиопатическим артритом, ингибиторами ФНО-альфа // Педиатр. 2014. Т. 5, № 4. С. 60–64. DOI: 10.17816/PED5460-64</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Gonchar NV, Slizovskij NV. Pathogenetic significance of comorbidity of juvenile rheumatoid arthritis and components of metabolic syndrome (literature review). Children’s medicine of the North-West. 2021;9(4): 23–32. (In Russ.)</mixed-citation><mixed-citation xml:lang="ru">Гончар Н.В., Слизовский Н.В. Патогенетическое значение коморбидности ювенильного ревматоидного артрита и компонентов метаболического синдрома (обзор литературы) // Детская медицина Северо-Запада. 2021. Т. 9, № 4. С. 23–32.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Davydova GA, Lisitsyna TA, Kovaleva LA, et al. Clinical variations of uveitis in immuno-inflammatory diseases. Review of the literature. Part 1. Ophthalmology in Russia. 2022;19(3):465–474. (In Russ.) DOI: 10.18008/1816-5095-2022-3-465-474</mixed-citation><mixed-citation xml:lang="ru">Давыдова Г.А., Лисицына Т.А., Ковалева Л.А., и др. Клинические вариации увеитов при иммуновоспалительных заболеваниях. Обзор литературы. Часть 1 // Офтальмология. 2022. Т. 19, № 3. С. 465–474. DOI: 10.18008/1816-5095-2022-3-465-474</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Fedorova EV, Egorov AS, Ammosova T, et al. Hypothesis about the protective role of CCR5delta32 mutations in juvenile idiopathic arthritis: fiction or reality? Pediatrician (St. Petersburg). 2014;5(4):53–59. (In Russ.) DOI: 10.17816/PED5453-59</mixed-citation><mixed-citation xml:lang="ru">Федорова Е.В., Егоров А.С., Аммосова Т., и др. Гипотеза о протективной роли мутации CCR5delta32 при Ювенильном Идиопатическом Артрите: миф или реальность? // Педиатр. 2014. Т. 5, № 4. С. 53–59. DOI: 10.17816/PED5453-59</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Chasnyk VG, Gaidar EV, Kononov AV, et al. Proteomic profile of tears for the diagnosis of uveitis associated with juvenile idiopathic arthritis: setting targets to achieve results. Pediatrician (St. Petersburg). 2017;8(1):5–26. (In Russ.) DOI: 10.17816/PED815-26</mixed-citation><mixed-citation xml:lang="ru">Часнык В.Г., Гайдар Е.В., Кононов А.В., и др. Протеомный профиль слезы в диагностике увеита, ассоциированного с ювенильным идиопатическим артритом: от постановки задачи до первых результатов // Педиатр. 2017. Т. 8, № 1. С. 5–26. DOI: 10.17816/PED815-26</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Angeles-Han ST, Ringold S, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2019;71(6): 703–716. DOI: 10.1002/acr.23871</mixed-citation><mixed-citation xml:lang="ru">Angeles-Han S.T., Ringold S., Beukelman T., et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis // Arthritis Care Res (Hoboken). 2019. Vol. 71, No. 6. P. 703–716. DOI: 10.1002/acr.23871</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Kalinina Ayuso V, ten Cate HAT, van der Does P, et al. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149(6):987–993. DOI: 10.1016/j.ajo.2010.01.014</mixed-citation><mixed-citation xml:lang="ru">Kalinina Ayuso V., ten Cate H.A.T., van der Does P., et al. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis // Am J Ophthalmol. 2010. Vol. 149, No. 6. P. 987–993. DOI: 10.1016/j.ajo.2010.01.014</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Chia A, Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135(6):757–762. DOI: 10.1016/S0002-9394(03)00225-3</mixed-citation><mixed-citation xml:lang="ru">Chia A., Lee V., Graham E.M., Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program // Am J Ophthalmol. 2003. Vol. 135, No. 6. P. 757–762. DOI: 10.1016/S0002-9394(03)00225-3</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Clarke SLN, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14(1):27. DOI: 10.1186/s12969-016-0088-2</mixed-citation><mixed-citation xml:lang="ru">Clarke S.L.N., Sen E.S., Ramanan A.V. Juvenile idiopathic arthritis-associated uveitis // Pediatr Rheumatol Online J. 2016. Vol. 14, No. 1. ID27. DOI: 10.1186/s12969-016-0088-2</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77(8):1107–1117. DOI: 10.1136/annrheumdis-2018-213131</mixed-citation><mixed-citation xml:lang="ru">Constantin T., Foeldvari I., Anton J., et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative // Ann Rheum Dis. 2018. Vol. 77, No. 8. P. 1107–1117. DOI: 10.1136/annrheumdis-2018-213131</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Foeldvari I, Becker I, Horneff G. Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry. Arthritis Care Res (Hoboken). 2015;67(11):1529–1535. DOI: 10.1002/acr.22613</mixed-citation><mixed-citation xml:lang="ru">Foeldvari I., Becker I., Horneff G. Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry // Arthritis Care Res (Hoboken). 2015. Vol. 67, No. 11. P. 1529–1535. DOI: 10.1002/acr.22613</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Kostik MM, Gaidar EV, Sorokina LS, et al. Uveitis is a risk factor for juvenile idiopathic arthritis’ significant flare in patients treated with biologics. Front Pediatr. 2022;10:849940. DOI: 10.3389/fped.2022.849940</mixed-citation><mixed-citation xml:lang="ru">Kostik M.M., Gaidar E.V., Sorokina L.S., et al. Uveitis is a risk factor for juvenile idiopathic arthritis’ significant flare in patients treated with biologics // Front Pediatr. 2022. Vol. 10. ID 849940. DOI: 10.3389/fped.2022.849940</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Kostik MM, Gaidar EV, Hynnes AY, et al. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. Clin Exp Rheumatol. 2016;34(4):714–718.</mixed-citation><mixed-citation xml:lang="ru">Kostik M.M., Gaidar E.V., Hynnes A.Y., et al. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use // Clin Exp Rheumatol. 2016. Vol. 34, No. 4. P. 714–718.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Maleki A, Anesi SD, Look-Why S, et al. Pediatric uveitis: A comprehensive review. Surv Ophthalmol. 2022;67(2): 510–529. DOI: 10.1016/j.survophthal.2021.06.006</mixed-citation><mixed-citation xml:lang="ru">Maleki A., Anesi S.D., Look-Why S., et al. Pediatric uveitis: A comprehensive review // Surv Ophthalmol. 2022. Vol. 67, No. 2. P. 510–529. DOI: 10.1016/j.survophthal.2021.06.006</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Papadopoulou C, Kostik M, Böhm M, et al. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. J Pediatr. 2013;163(3):879–884. DOI: 10.1016/j.jpeds.2013.03.047</mixed-citation><mixed-citation xml:lang="ru">Papadopoulou C., Kostik M., Böhm M., et al. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis // J Pediatr. 2013. Vol. 163, No. 3. P. 879–884. DOI: 10.1016/j.jpeds.2013.03.047</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–402.</mixed-citation><mixed-citation xml:lang="ru">Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 // J Rheumatol. 2004. Vol. 31, No. 2. P. 390–402.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–778. DOI: 10.1016/S0140-6736(07)60363-8</mixed-citation><mixed-citation xml:lang="ru">Ravelli A., Martini A. Juvenile idiopathic arthritis // Lancet. 2007. Vol. 369, No. 9563. P. 767–778. DOI: 10.1016/S0140-6736(07)60363-8</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Clin Immunol. 2020;211:108322. DOI: 10.1016/j.clim.2019.108322</mixed-citation><mixed-citation xml:lang="ru">Sen E.S., Ramanan A.V. Juvenile idiopathic arthritis-associated uveitis // Clin Immunol. 2020. Vol. 211. ID108322. DOI: 10.1016/j.clim.2019.108322</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Vinokurova F, Sorokina L, Argunova V, et al. POS1297 HOW HLA B27 prevalence in the population influence on features of juvenile idiopathic arthritis: data from Sakha Republic (Yakutia). Ann Rheum Dis. 2021;80(S1):930. DOI: 10.1136/annrheumdis-2021-eular.810</mixed-citation><mixed-citation xml:lang="ru">Vinokurova F., Sorokina L., Argunova V., et al. POS1297 HOW HLA B27 prevalence in the population influence on features of juvenile idiopathic arthritis: data from Sakha Republic (Yakutia) // Ann Rheum Dis. 2021. Vol. 80, No. S1. ID 930. DOI: 10.1136/annrheumdis-2021-eular.810</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63(7):929–936. DOI: 10.1002/acr.20497</mixed-citation><mixed-citation xml:lang="ru">Wallace C.A., Giannini E.H., Huang B., et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis // Arthritis Care Res (Hoboken). 2011. Vol. 63, No. 7. P. 929–936. DOI: 10.1002/acr.20497</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Yasumura J, Yashiro M, Okamoto N, et al. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ). Pediatr Rheumatol. 2019;17:15. DOI: 10.1186/s12969-019-0318-5</mixed-citation><mixed-citation xml:lang="ru">Yasumura J., Yashiro M., Okamoto N., et al. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ) // Pediatr Rheumatol. 2019. Vol. 17. ID 15. DOI: 10.1186/s12969-019-0318-5</mixed-citation></citation-alternatives></ref></ref-list></back></article>
